Dr. Stock is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1703 Chantilly Lane
Chester Springs, PA 19425
Summary
- PHARMACEUTICAL CLINICAL DEVELOPMENT AND OPERATIONS EXECUTIVE.
Accomplished, highly analytical, change agile, drug development leader and consultant with extensive experience overseeing and directing clinical research programs through all phases of clinical development and regulatory approval. Proven history of providing senior-level clinical, scientific, operational, and strategic guidance to program teams. Deep background in leading, planning, designing, conducting, and reporting clinical studies and clinical program/portfolio management. Unique qualifications in Clinical Pharmacology Research Unit operation and management. Exemplary team leadership, talent development, critical thinking, problem solving, and process improvement abilities. Successful collaborations with multi-disciplinary peer subject matter experts to positively influence scientific, clinical, and operational advances through novel study/program design and best practices. Key areas of expertise:
Clinical Program Planning and Study Design |Phase 1 to 4 Clinical Study Conduct and Reporting | Regulatory Authority Submissions and Drug Approvals | Inflammation and Immunology Therapy Area Expertise | Clinical Pharmacology | Translational Medicine |Model Informed Drug Development | Clinical Pharmacology Research Unit Leadership | Development Operations |Organizational Design and Change Management |
Leadership, Portfolio Governance, and Team Building
Education & Training
- Des Moines University College of Osteopathic MedicineClass of 1990
Certifications & Licensure
- MI State License Active through 2026
- American Board of Family Medicine Family Medicine
Publications & Presentations
PubMed
- 164 citationsModel‐Based Drug Development: A Rational Approach to Efficiently Accelerate Drug DevelopmentPeter A. Milligan, M.J. Brown, B Marchant, Steven W. Martin, P H van der Graaf
Clinical Pharmacology and Therapeutics. 2013-06-01 - 15 citationsModified- versus immediate-release tofacitinib in Japanese rheumatoid arthritis patients: a randomized, phase III, non-inferiority studyYoshiya Tanaka, Naonobu Sugiyama, Shigeyuki Toyoizumi, Tatjana Lukic, Manisha Lamba
Rheumatology. 2019-01-01 - 190 citationsEfficacy and safety of CE-224,535, an antagonist of P2X7 receptor, in treatment of patients with rheumatoid arthritis inadequately controlled by methotrexate.Thomas C. Stock, Bradley J. Bloom, Nathan Wei, Saliha Ishaq, Won Park
The Journal of Rheumatology. 2012-04-01
Professional Memberships
- Member
- Member
External Links
- LinkedInhttp://www.linkedin.com/in/thomas-stock
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: